Express Scripts recently published their report of the most recent FDA Update. The team focused on several U.S. Food and Drug Administration approvals for new drugs, generics and indications. The article highlights the following topics:
Generics to Seroquel XR Launched
New Indication for Enbrel
Vemlidy Approved for Hepatitis B
Opdivo Gains New Indication
Soliqua and Xultophy Approved for Type 2 Diabetes
Stay informed by reading the full article HERE!
HORIZON Health Ventures is a healthcare cost management solutions company used by insurance
brokers, employee benefit consultants, third-party administrators,
insurance companies, and associations, to bring proven thought
leadership and strategy to the management of their clients healthcare
costs. To learn more about HHV and their services, please visit http://horizonhealthventures.com/
No comments:
Post a Comment